David Sefrioui

8PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 16, 2025
ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer.

Adrien Grancher, Ludivine Beaussire-Trouvay, Virginie Vernon

|Jul 14, 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.

Cécile Torregrosa, Simon Pernot, Pauline Vaflard

|Apr 24, 2022
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.

Sahir Javed, Stéphane Benoist, Patrick Devos

|Oct 08, 2021
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization.

David Sefrioui, Vincent Verdier, Céline Savoye-Collet

Pageof 2